GW Pharmaceuticals PLC (GWPH) Drug Data Bursts Bears' Bubble

Analysts are seemingly the only ones with faith in GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH)

Dec 24, 2015 at 10:14 AM
facebook X logo linkedin


Bears have been feasting on GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) recently, as the shares have lost almost half their value since hitting a record peak of $133.98 in late June, while underperforming the S&P 500 Index (SPX) by roughly 32 percentage points during the past three months. For instance, short sellers control 9% of the stock's float. At average daily volumes, it would take almost six sessions for them to buy back their short shares. 

Option traders, too, have taken the bearish road. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), GWPH's 10-day put/call volume ratio stands at 5.61, which is just 4 percentage points from an annual peak. In other words, there's been a greater-than-usual appetite for long puts over long calls recently.

Echoing this, the biotech stock's Schaeffer's put/call open interest ratio (SOIR) comes in at 1.72, showing put open interest outweighs call open interest by a wide margin, at least among options that expire within the next three months. What's more, this SOIR is higher than 91% of readings from the past year, revealing short-term speculators are more put-skewed than normal. 

On the other hand, analysts have remained fully in the bulls' corner. All six brokerage firms that track GWPH say it's at least a "buy," and its average 12-month price target resides at $138.83 -- about two times current levels. 

And today, analysts look like the smart ones, with GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) 2.9% higher at $69.06. The shares are getting a lift from a journal article that said the drug company's epilepsy treatment, Epidiolex, was able to reduce the frequency of seizures among patients.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI